Search Results 311-320 of 17081 for pharmacogenetics
William A. Faubion Jr., M.D., who leads the Immuno-Epigenetics Lab, is a mentor and director for several education programs at Mayo Clinic.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
The purpose of this study is to characterize the immunophenotype of individuals with hypereosinophilia-associated cardiovascular, gastrointestinal, hematologic, ...
The purpose of this study is to compare the effects on low-risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no ...
Marla Broadfoot, Ph.D. October 14, 2025. Mayo Clinic researchers discover 'traffic controller' protein that protects DNA, and may help.
As a new year approaches, here's a look back at 10 of Mayo Clinic's influential precision medicine research studies in 2021. Highlights include treating ...
About this study. The purpose of this study is to evaluate clinical complications, pattern of kidney function decline and identification of clinical ...
A small subset of the women who get diagnosed have inherited an abnormal copy of a gene that runs in families and can greatly increase their risk of certain ...
Mayo Clinic specialists offer advanced care for young people with colorectal, appendiceal, pancreatic, gastric, bile duct or other GI cancers.
2013 Dec 1; 591(Pt 23):5805-6. View PubMed; Beatty NC, Nicholson WT, Langman LJ, Curry TB, Eisenach JH. Pharmacogenetic workup of perioperative serotonin ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!